- Genomic Data-as-a-Service (GDaaS) is a critical solution that enables the storage, analysis, and sharing of large-scale genomic data, supporting research, precision medicine, drug discovery, and population health studies. It provides researchers and healthcare professionals with high-throughput, real-time access to complex genetic information
- The demand for GDaaS is significantly driven by the increasing adoption of personalized medicine, advancements in next-generation sequencing (NGS) technologies, and the growing need for large-scale data analytics in genomics
- North America is expected to dominate the Genomic Data-as-a-Service (GDaaS) market with a market share of 47.6% driven by advanced healthcare infrastructure, high adoption of cutting-edge genomic technologies, and a strong presence of key market players
- Asia-Pacific is expected to be the fastest growing region in the Genomic Data-as-a-Service (GDaaS) market with a market share of 26.9% driven by rapid expansion in healthcare infrastructure, increasing awareness about personalized medicine, and rising demand for genetic testing
- Next-generation sequencing (NGS) segment is expected to dominate the market with a market share of 58.6%, due to its ability to rapidly and accurately sequence entire genomes, transcriptomes, and targeted regions at a fraction of the cost and time of traditional methods
